𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bone turnover markers: understanding their value in clinical trials and clinical practice

✍ Scribed by R. Civitelli; R. Armamento-Villareal; N. Napoli

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
192 KB
Volume
20
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II clinical trial does not show
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
✍ TE Sondergaard; PT Pedersen; TL Andersen; K SΓΈe; T Lund; B Østergaard; P Garnero πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract Several studies have evaluated the impact of low dose statin (20–80 mg/day) on bone metabolism with inconclusive results despite promising data of preclinical studies. In this study, we investigated the effect of high dose simvastatin (HD‐Sim) on biochemical markers of bone turnover and